rs17606561, ELOVL2

N. diseases: 2
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Phospholipid measurement
CUI: C0202177
Disease: Phospholipid measurement
0.800 GeneticVariation GWASDB Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium. 21829377 2011
Phospholipid measurement
CUI: C0202177
Disease: Phospholipid measurement
0.800 GeneticVariation GWASDB Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations. 22359512 2012
Phospholipid measurement
CUI: C0202177
Disease: Phospholipid measurement
0.800 GeneticVariation GWASCAT Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations. 22359512 2012
Autism Spectrum Disorders
CUI: C1510586
Disease: Autism Spectrum Disorders
0.010 GeneticVariation BEFREE FADS2 rs526126 and ELOVL2 rs10498676 were associated with decreased ASD risk in recessive model (OR = 0.07, 95% CI = 0.02-0.22, p<sub>FDR</sub> < 0.01; OR = 0.56, 95% CI = 0.35-0.89, p<sub>FDR</sub> = 0.042), while ELOVL2 rs17606561, rs3756963, and rs9468304 were associated with increased ASD risk in overdominant model (OR = 1.63, 95% CI = 1.12-2.36, p<sub>FDR</sub> = 0.036; OR = 1.64, 95% CI = 1.14-2.37, p<sub>FDR</sub> = 0.039; OR = 1.75, 95% CI = 1.22-2.50, p<sub>FDR</sub> = 0.017). 30180836 2018